Pravastatin sodium and Scab - a phase IV clinical study of FDA data

Summary:

Scab is reported as a side effect among people who take Pravastatin sodium (pravastatin sodium), especially for people who are female, 60+ old, have been taking the drug for 5 - 10 years also take Vitamin D3, and have Primary myelofibrosis.

The phase IV clinical study analyzes which people have Scab when taking Pravastatin sodium. It is created by eHealthMe based on reports of 23,888 people who have side effects when taking Pravastatin sodium from the FDA, and is updated regularly.

What is Pravastatin sodium?

Pravastatin sodium has active ingredients of pravastatin sodium. It is often used in high blood cholesterol. eHealthMe is studying from 26,520 Pravastatin sodium users. Check the latest studies of Pravastatin sodium.

What is Scab?

Scab (a hard coating on the skin formed during the wound healing) is found to be associated with 839 drugs and 1,081 conditions by eHealthMe. Check the latest studies of Scab.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 03, 2026

23,888 people reported to have side effects when taking Pravastatin sodium.
Among them, 30 people (0.13%) have Scab.

Among these 30 people:

How long have people been on Pravastatin sodium when they have Scab? *

What is the gender of people who have Scab when taking Pravastatin sodium? *

female: 76.19 %
male: 23.81 %

What is the age of people who have Scab when taking Pravastatin sodium? *

What are other drugs people take besides Pravastatin sodium? *

What are other side effects people have besides Scab? *

Itching: 16 people, 53.33%
Rashes (redness): 15 people, 50.00%
Herpes Zoster: 11 people, 36.67%
Skin Discoloration: 10 people, 33.33%
Cough: 10 people, 33.33%
Diarrhea: 9 people, 30.00%
Dyspnea Exertional: 9 people, 30.00%
Decreased Activity: 8 people, 26.67%
Fatigue (feeling of tiredness): 8 people, 26.67%
Anaemia (lack of blood): 8 people, 26.67%

What are the existing conditions these people have? *

Primary Myelofibrosis (primary disorder of the bone marrow): 8 people, 26.67%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 6 people, 20.00%
Pain: 5 people, 16.67%
Diabetes: 5 people, 16.67%
Glaucoma (increased fluid pressure in the eye with vision loss): 5 people, 16.67%
Dry Eyes (lack of adequate tears): 3 people, 10.00%
Stable Angina (a constant chest pain): 3 people, 10.00%
Hypotension (abnormally low blood pressure): 3 people, 10.00%
Polycythaemia Vera (blood disorder in which the bone marrow makes too many red blood cells): 3 people, 10.00%
Mycosis Fungoides (lymphocytes (a type of white blood cell) become malignant (cancerous) and affect the skin): 2 people, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Pravastatin sodium and have Scab?

- Check whether Scab is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Pravastatin sodium:

Pravastatin sodium (26,520 reports)

Scab treatments and more:

Scab (12,679 reports)

Browse all side effects of Pravastatin sodium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Scab:

Scab (839 drugs)

Browse all the conditions that are associated with Scab:

Scab (1,081 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on pravastatin sodium (the active ingredients of Pravastatin sodium) and Pravastatin sodium (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.